Evidence map›Paper›PMID 36620568›Full record

ReviewFrontiers in oncology2022

Cancer diagnosis in areas of conflict.

Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Ali Mohamedkhair, Miriam Mikhail-Lette, Mohammad Al-Qudah, Diana Paez, Asem H Mansour

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Liver disease care amid wars and conflicts.Nature reviews. Gastroenterology & hepatology · 2026
    Article
  5. Review
  6. Theranostics and nuclear medicine practice in Asia-Pacific: an IAEA regional study.European journal of nuclear medicine and molecular imaging · 2026
    Review
  7. Review
  8. Article
  9. Nuclear Medicine in IRAQ: From a Pioneering Past to Future Progress.Journal of multidisciplinary healthcare · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Theranostics and molecular imaging training in the arab world: present and prospects.European journal of nuclear medicine and molecular imaging · 2024
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
Ahmed Saad AbdlkadirDepartment of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
Ali MohamedkhairDepartment of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
Miriam Mikhail-LetteNuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
Mohammad Al-QudahDepartment of Microbiology and Pathology - Faculty of Medicine - The Hashemite University, Zarqa, Jordan.
Diana PaezNuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
Asem H MansourDepartment of Diagnostic Radiology, King Hussein Cancer Center, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, many Arab countries within the Middle East are facing political, financial, and social instability from war and conflicts. These conflicts have led to severe resources shortages and sometimes complete breakdowns in cancer care and diagnosis. Cancer diagnosis at early stages is the most vital step in achieving optimal cancer care and outcomes. Shortages in cancer diagnostic services have meant that many people within areas of conflict are ultimately deprived of these services in their own countries. Therefore, many of these cancer sufferers must bear travel expenses to neighboring countries in order to seek these services. A lack of prevention, screening, and diagnostic services for this population is known to deepen the cancer care deficit within these areas. Additionally, the financial burden of traveling abroad alongside the need to secure childcare and time off work can be overwhelming. As a result, patients within areas of conflict are frequently diagnosed at later stages and are less likely to receive optimal management plans. Though conflict-affected regions encounter many similar challenges in delivering quality cancer care, pronounced region-specific differences do exist. Therefore, it is important to build a roadmap that can provide tailored solutions to deficits in instruments, manpower, and facilities for each and every region involved. Keeping in mind the importance of collaboration and coordination on national and international levels to address the ground disparity in cancer diagnostic services, the main objective of this review article is to examine the significant problems, shortages, and difficulties in providing cancer diagnosis with a focus on imaging to conflict-affected populations in the Middle East (mainly Iraq, Syria, Yemen, and Sudan). Finally, we discuss how access to cancer diagnostic imaging services has been impacted by these conflicts.

Indexed as

cancer diagnosisconflictimagingMiddle Eastrefugeesresourceswar

Identifiers

PMID36620568
PMCPMC9815758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.